Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death in patients worldwide and yet often goes undiagnosed. Although genetic risk plays a significant role in susceptibility to COPD, it is unclear whether it is helpful in performing spirometry tests and identifying undiagnosed cases. American researchers investigated whether a polygenic risk score improves the identification of undiagnosed COPD beyond the conventional approach to case finding.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Cystic fibrosis
Small spray – big footprint
- From symptom to diagnosis
Abdominal pain – Gastric outlet stenosis
- When the bones become more fragile: “Case Finding”
Fracture risk reduction in osteoporosis
- Biologics for plaque psoriasis
What increases the chance of a sustained remission?
- Pain and autism
Hurdles to pain treatment for autistic patients
- Findings from the ALS Symposium 2024 in Montreal
Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
- Long-COVID
Increased risk with asthma and COPD
- Atopic dermatitis in children